| scholarly article | Q13442814 |
| P2093 | author name string | D C Hooper | |
| J S Wolfson | |||
| M N Swartz | |||
| G L McHugh | |||
| M A Bozza | |||
| P2860 | cites work | hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis | Q24685235 |
| DNA topoisomerases | Q28264119 | ||
| Properties of the Penicillin-Binding Proteins of Escherichia coli K12 | Q28292803 | ||
| Pedigrees of some mutant strains of Escherichia coli K-12 | Q33851231 | ||
| A model for three-point analysis of random general transduction | Q33983304 | ||
| Distinct penicillin binding proteins involved in the division, elongation, and shape of Escherichia coli K12 | Q35085145 | ||
| In vitro cleavable-complex assay to monitor antimicrobial potency of quinolones | Q35314754 | ||
| Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K-12 | Q35315975 | ||
| Isolation and characterization of an Escherichia coli strain exhibiting partial tolerance to quinolones | Q35332818 | ||
| Conditional impairment of cell division and altered lethality in hipA mutants of Escherichia coli K-12. | Q36209472 | ||
| Penicillin-binding protein 7 and its relationship to lysis of nongrowing Escherichia coli. | Q36270438 | ||
| Molecular cloning and expression of hipA, a gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis | Q36284557 | ||
| Use of phi(glp-lac) in studies of respiratory regulation of the Escherichia coli anaerobic sn-glycerol-3-phosphate dehydrogenase genes (glpAB) | Q36297516 | ||
| Role of sulA and sulB in filamentation by lon mutants of Escherichia coli K-12. | Q36308395 | ||
| Evidence for involvement of penicillin-binding protein 3 in murein synthesis during septation but not during cell elongation | Q36323172 | ||
| Coupling of DNA replication and cell division: sulB is an allele of ftsZ | Q36330533 | ||
| Single-strand breaks in deoxyribonucleic acid and viability loss during deoxyribonucleic acid synthesis inhibition in Escherichia coli | Q36767283 | ||
| Nalidixic Acid and the Metabolism of Escherichia coli | Q36789014 | ||
| Specific loss of newly replicated deoxyribonucleic acid in nalidixic acid-treated Bacillus subtilis 168. | Q36819495 | ||
| Bacterial Cell Division Regulation: Lysogenization of Conditional Cell Division lon − Mutants of Escherichia coli by Bacteriophage Lambda | Q36838794 | ||
| Evidence for a Relationship Between Deoxyribonucleic Acid Metabolism and Septum Formation in Escherichia coli | Q36846266 | ||
| Biology of bacterial deoxyribonucleic acid topoisomerases | Q37066515 | ||
| Mode of action of the quinolone antimicrobial agents: review of recent information | Q38286334 | ||
| DNA topoisomerase poisons as antitumor drugs | Q38286727 | ||
| Inhibitors of DNA topoisomerases | Q39222432 | ||
| From penicillin-binding proteins to the lysis and death of bacteria: a 1979 view | Q39307860 | ||
| DNA synthesis inhibition and the induction of protein X in Escherichia coli | Q39376375 | ||
| Recent studies of DNA topoisomerases | Q39509135 | ||
| Investigations into the mechanism of action of the antibacterial agent norfloxacin | Q39554718 | ||
| Membrane permeability changes associated with DNA gyrase inhibitors in Escherichia coli | Q39850145 | ||
| Evaluation of oxacillin tolerance in Staphylococcus aureus by a novel method | Q39850270 | ||
| Evaluation of the in vitro bactericidal action of ciprofloxacin on cells of Escherichia coli in the logarithmic and stationary phases of growth | Q39850437 | ||
| Cell shape and division in Escherichia coli: experiments with shape and division mutants | Q39981015 | ||
| MECHANISM OF ACTION OF NALIDIXIC ACID ON ESCHERICHIA COLI.II. INHIBITION OF DEOXYRIBONUCLEIC ACID SYNTHESIS. | Q40250988 | ||
| MECHANISM OF ACTION OF NALIDIXIC ACID ON ESCHERICHIA COLI | Q40434566 | ||
| Mechanism of Action of Nalidixic Acid on Escherichia coli III. Conditions Required for Lethality | Q40434882 | ||
| Mechanism of Action of Nalidixic Acid on Escherichia coli IV. Effects on the Stability of Cellular Constituents | Q40434889 | ||
| Nalidixic Acid: an Antibacterial Paradox | Q40944835 | ||
| Alteration of bacterial DNA structure, gene expression, and plasmid encoded antibiotic resistance following exposure to enoxacin. | Q54389866 | ||
| The response of Escherichia coli to ciprofloxacin and norfloxacin. | Q54412363 | ||
| Phenotypic resistance to antimicrobial agents. | Q54449558 | ||
| Influence of ciprofloxacin on the ultrastructure of gram-negative and gram-positive bacteria. | Q54462525 | ||
| DNA breakdown by the 4-quinolones and its significance. | Q54718474 | ||
| 4-quinolones and the SOS response. | Q54729255 | ||
| Bactericidal mechanisms of ofloxacin. | Q54742926 | ||
| Morphological and biochemical changes in Escherichia coli after exposure to ciprofloxacin. | Q54773512 | ||
| Antibiotic Tolerance Among Clinical Isolates of Bacteria | Q57077300 | ||
| Nalidixic acid and bacterial chromosome replication | Q59071237 | ||
| Induction of the SOS response by new 4-quinolones | Q68220052 | ||
| Biological role of the pneumococcal amidase. Cloning of the lytA gene in Streptococcus pneumoniae | Q68988528 | ||
| Fluoroquinolone antimicrobial agents | Q69548929 | ||
| Bactericidal effect against Escherichia coli of nalidixic acid and four structurally related compounds | Q72620620 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | quinolones | Q426549 |
| Escherichia coli K-12 | Q21399437 | ||
| P304 | page(s) | 1938-1943 | |
| P577 | publication date | 1990-10-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Mutants of Escherichia coli K-12 exhibiting reduced killing by both quinolone and beta-lactam antimicrobial agents | |
| P478 | volume | 34 |
| Q46346666 | An Experimental Framework for Quantifying Bacterial Tolerance |
| Q39932553 | Autoregulation of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis |
| Q24544968 | Bacterial persistence: a model of survival in changing environments |
| Q34932825 | Bacterial persistence: some new insights into an old phenomenon |
| Q43116681 | Biofilms 2003: emerging themes and challenges in studies of surface-associated microbial life |
| Q24548874 | Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials |
| Q30781159 | Campylobacter and fluoroquinolones: a bias data set? |
| Q91726590 | Candida albicans Biofilms Are Generally Devoid of Persister Cells |
| Q40148460 | Contribution of the Chromosomal ccdAB Operon to Bacterial Drug Tolerance. |
| Q36301709 | Converting cancer therapies into cures: lessons from infectious diseases |
| Q26825267 | Culture history and population heterogeneity as determinants of bacterial adaptation: the adaptomics of a single environmental transition |
| Q93066235 | Definitions and guidelines for research on antibiotic persistence |
| Q53789924 | Distinguishing between resistance, tolerance and persistence to antibiotic treatment. |
| Q38313217 | Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation |
| Q34309282 | Emergence of Pseudomonas aeruginosa Strains Producing High Levels of Persister Cells in Patients with Cystic Fibrosis |
| Q95933645 | Evolutionary causes and consequences of bacterial antibiotic persistence |
| Q33248634 | GlpD and PlsB participate in persister cell formation in Escherichia coli |
| Q36121601 | Induction of Multidrug Tolerance in Plasmodium falciparum by Extended Artemisinin Pressure |
| Q43126277 | Isolation of highly persistent mutants of Salmonella enterica serovar typhimurium reveals a new toxin-antitoxin module |
| Q39559720 | Joint tolerance to beta-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA. |
| Q40621958 | Killing by ampicillin and ofloxacin induces overlapping changes in Escherichia coli transcription profile. |
| Q89581893 | Loss of phenotypic inheritance associated with ydcI mutation leads to increased frequency of small, slow persisters in Escherichia coli |
| Q72092628 | Mechanisms of Resistance to Quinolones |
| Q28252446 | Microbial cell individuality and the underlying sources of heterogeneity |
| Q31033209 | Mode of action of the new quinolones: New data |
| Q39782108 | Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones. |
| Q42747648 | Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1. |
| Q35106198 | Novel protocol for persister cells isolation. |
| Q54285098 | Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations. |
| Q44735515 | Persister cells and tolerance to antimicrobials |
| Q26748708 | Persisters-as elusive as ever |
| Q34573964 | Quantitative analysis of persister fractions suggests different mechanisms of formation among environmental isolates of E. coli |
| Q40489458 | Quinolone Mode of Action - New Aspects† |
| Q36921143 | Quinolone-mediated bacterial death. |
| Q36758128 | Relationships among antibacterial activity, inhibition of DNA gyrase, and intracellular accumulation of 11 fluoroquinolones |
| Q24550611 | Riddle of biofilm resistance |
| Q30481748 | Single-cell protein induction dynamics reveals a period of vulnerability to antibiotics in persister bacteria. |
| Q37663571 | Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli |
| Q37768788 | Stochastic mechanisms of cell fate specification that yield random or robust outcomes. |
| Q34941745 | The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress. |
| Q38103861 | The intrinsic resistome of bacterial pathogens |
| Q33280142 | Why is long-term therapy required to cure tuberculosis? |
| Q83025534 | [Bacterial death and heteroresistance to antimicrobial agents] |
| Q40697356 | l-Serine potentiates fluoroquinolone activity against Escherichia coli by enhancing endogenous reactive oxygen species production. |
Search more.